---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027781"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2026-06-08T21:53:19+00:00"
generated_at: "2026-06-09T10:08:33.237102+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Enveric Biosciences releases Q2 2026 investor presentation; no specific updates

## Summary
- Investor presentation made available on June 8, 2026 via company website.
- Materials intended for use in discussions with investors, analysts, and partners.
- No financial results, guidance, or operational milestones disclosed in filing.
- Presentation may be modified and reused in future stakeholder meetings.

## SEC filing metadata
- accession: 0001493152-26-027781
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2026-06-08T21:53:19+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315226027781/0001493152-26-027781-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315226027781/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027781
- JSON: https://secwatch.observer/filing/0001493152-26-027781.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027781.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.